Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
6-Month Effects of Fingolimod on Indexes of Cardiovascular Autonomic Control in Multiple Sclerosis.
Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells.
Effects of exercise in a relapsing-remitting model of experimental autoimmune encephalomyelitis.
Ballroom Dance for Persons with Multiple Sclerosis: Physical and Cognitive Efficacy: 2997 Board #62 June 3, 3: 30 PM - 5: 00 PM.
Dynamic pattern of clinical and MRI findings in a tumefactive demyelinating lesion: A case report.
The Pharmacokinetics and Dosing of Oral 4-Methylumbelliferone for Inhibition of Hyaluronan Synthesis in Mice.
Future placebo-controlled trials of disease modifying therapy in relapsing multiple sclerosis would be unethical: No.
Neuroanatomic Correlates of Female Sexual Dysfunction in Multiple Sclerosis.
The effectiveness of the Permission, Limited Information, Specific suggestions, Intensive Therapy (PLISSIT) model based sexual counseling on the sexual function of women with Multiple Sclerosis who are sexually active.
MTR recovery in brain lesions in the BECOME study of glatiramer acetate vs interferon β-1b.
Effectiveness and safety of natalizumab in real-world clinical practice: Review of observational studies.
Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial.
The 11-year long-term follow-up study from the randomized BENEFIT CIS trial.
Predictors of first-line treatment persistence in a Portuguese cohort of relapsing-remitting multiple sclerosis.
The Role of Biogenic Amines in the Regulation of Interaction between the Immune and Nervous Systems in Multiple Sclerosis.
Dendritic cells tip the balance towards induction of regulatory T cells upon priming in experimental autoimmune encephalomyelitis.
The contribution of depressive symptoms to slowness of information processing in relapsing remitting multiple sclerosis.
Multiple sclerosis : understanding a complex neurological condition.
Chronic lung disease and multiple sclerosis: Incidence, prevalence, and temporal trends.
Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy.
Between genetics and biology. Is ENMG useful in peripheral neuropathy diagnosis and management?
The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients.
An emerging role for eotaxins in neurodegenerative disease.
A case of intravenous immunoglobulin-dependent chronic inflammatory demyelinating polyneuropathy of pure motor form responsive to mycophenolate mofetil therapy.
Corrigendum.
Pages
« first
‹ previous
…
783
784
785
786
787
788
789
790
791
…
next ›
last »